Literature DB >> 17395768

The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.

Adriana López Ponte1, Emeline Marais, Nathalie Gallay, Alain Langonné, Bruno Delorme, Olivier Hérault, Pierre Charbord, Jorge Domenech.   

Abstract

Adult bone marrow (BM)-derived stem cells, including hematopoietic stem cells (HSCs) and MSCs, represent an important source of cells for the repair of a number of damaged tissues. In contrast to HSCs, the soluble factors able to induce MSC migration have not been extensively studied. In the present work, we compared the in vitro migration capacity of human BM-derived MSCs, preincubated or not with the inflammatory cytokines interleukin 1beta (IL1beta) and tumor necrosis factor alpha (TNFalpha), in response to 16 growth factors (GFs) and chemokines. We show that BM MSCs migrate in response to many chemotactic factors. The GFs platelet-derived growth factor-AB (PDGF-AB) and insulin-like growth factor 1 (IGF-1) are the most potent, whereas the chemokines RANTES, macrophage-derived chemokine (MDC), and stromal-derived factor-1 (SDF-1) have limited effect. Remarkably, preincubation with TNFalpha leads to increased MSC migration toward chemokines, whereas migration toward most GFs is unchanged. Consistent with these results, BM MSCs express the tyrosine kinase receptors PDGF-receptor (R) alpha, PDGF-Rbeta, and IGF-R, as well as the RANTES and MDC receptors CCR2, CCR3, and CCR4 and the SDF-1 receptor CXCR4. TNFalpha increases CCR2, CCR3, and CCR4 expression (as opposed to that of CXCR4), together with RANTES membrane binding. These data indicate that the migration capacity of BM MSCs is under the control of a large range of receptor tyrosine kinase GFs and CC and CXC chemokines. Most chemokines are more effective on TNFalpha-primed cells. Our results suggest that the mobilization of MSCs and their subsequent homing to injured tissues may depend on the systemic and local inflammatory state. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395768     DOI: 10.1634/stemcells.2007-0054

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  328 in total

1.  Allogenic platelet gel in the treatment of pressure sores: a pilot study.

Authors:  Silvia Scevola; Giovanni Nicoletti; Federica Brenta; Paola Isernia; Marcello Maestri; Angela Faga
Journal:  Int Wound J       Date:  2010-04-23       Impact factor: 3.315

2.  In vitro effects of direct current electric fields on adipose-derived stromal cells.

Authors:  Kyle E Hammerick; Michael T Longaker; Fritz B Prinz
Journal:  Biochem Biophys Res Commun       Date:  2010-05-07       Impact factor: 3.575

3.  Fibrin-embedded adipose derived stem cells enhance skin flap survival.

Authors:  Matthias A Reichenberger; Wolf Mueller; Amelia Schäfer; Sina Heimer; Uwe Leimer; Ulrike Lass; Günter Germann; Eva Köllensperger
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 4.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 5.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

6.  Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Authors:  Jing Huang; Zhiping Zhang; Jian Guo; Aiguo Ni; Arjun Deb; Lunan Zhang; Maria Mirotsou; Richard E Pratt; Victor J Dzau
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

Review 7.  Mesenchymal stem cells: Mechanisms of immunomodulation and homing.

Authors:  Hiroshi Yagi; Alejandro Soto-Gutierrez; Biju Parekkadan; Yuko Kitagawa; Ronald G Tompkins; Naoya Kobayashi; Martin L Yarmush
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

8.  Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue.

Authors:  Naghmeh Ahmadian Kia; Ahmad Reza Bahrami; Marzieh Ebrahimi; Maryam M Matin; Zeinab Neshati; Mahmood Rais Almohaddesin; Naser Aghdami; Hamid Reza Bidkhori
Journal:  J Mol Neurosci       Date:  2010-10-12       Impact factor: 3.444

9.  Cell-based therapies for regenerating bone.

Authors:  S B Goodman
Journal:  Minerva Ortop Traumatol       Date:  2013-04-01

10.  Hyperlipidemia compromises homing efficiency of systemically transplanted BMSCs and inhibits bone regeneration.

Authors:  Quan-Chen Xu; Peng-Jie Hao; Xin-Bo Yu; Shu-Lan Chen; Mei-Jiao Yu; Jin Zhang; Pi-Shan Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.